RSS feed

Publications by Marit Elise Hystad

25 publications found

Original articles

Celis P, Ferry N, Hystad M, Schüßler-Lenz M, Doevendans PA, Flory E, Beuneu C, Reischl I, Salmikangas P (2015)
Advanced Therapy Medicinal Products: How to Bring Cell-Based Medicinal Products Successfully to the Market - Report from the CAT-DGTI-GSCN Workshop at the DGTI Annual Meeting 2014
Transfus Med Hemother, 42 (3), 194-9
DOI 10.1159/000382107, PubMed 26195933

Brodtkorb M, Lingjærde OC, Huse K, Trøen G, Hystad M, Hilden VI, Myklebust JH, Leich E, Rosenwald A, Delabie J, Holte H, Smeland EB (2013)
Whole-genome integrative analysis reveals expression signatures predicting transformation in follicular lymphoma
Blood, 123 (7), 1051-4
DOI 10.1182/blood-2013-07-512392, PubMed 24357726

Hystad M, Modanese C, Di Sabatino M, Arnberg L (2012)
Distribution and impact of chromium in compensated solar grade silicon
Sol. Energy Mater. Sol. Cells, 103, 140-146
DOI 10.1016/j.solmat.2012.04.033

Eide MB, Liestøl K, Lingjaerde OC, Hystad ME, Kresse SH, Meza-Zepeda L, Myklebost O, Trøen G, Aamot HV, Holte H, Smeland EB, Delabie J (2010)
Genomic alterations reveal potential for higher grade transformation in follicular lymphoma and confirm parallel evolution of tumor cell clones
Blood, 116 (9), 1489-97
DOI 10.1182/blood-2010-03-272278, PubMed 20505157

Døsen-Dahl G, Munthe E, Nygren MK, Stubberud H, Hystad ME, Rian E (2008)
Bone marrow stroma cells regulate TIEG1 expression in acute lymphoblastic leukemia cells: role of TGFbeta/BMP-6 and TIEG1 in chemotherapy escape
Int J Cancer, 123 (12), 2759-66
DOI 10.1002/ijc.23833, PubMed 18798273

Sivertsen EA, Huse K, Hystad ME, Kersten C, Smeland EB, Myklebust JH (2007)
Inhibitory effects and target genes of bone morphogenetic protein 6 in Jurkat TAg cells
Eur J Immunol, 37 (10), 2937-48
DOI 10.1002/eji.200636759, PubMed 17899540

Hystad ME, Myklebust JH, Bø TH, Sivertsen EA, Rian E, Forfang L, Munthe E, Rosenwald A, Chiorazzi M, Jonassen I, Staudt LM, Smeland EB (2007)
Characterization of early stages of human B cell development by gene expression profiling
J Immunol, 179 (6), 3662-71
DOI 10.4049/jimmunol.179.6.3662, PubMed 17785802

Nygren MK, Døsen G, Hystad ME, Stubberud H, Funderud S, Rian E (2006)
Wnt3A activates canonical Wnt signalling in acute lymphoblastic leukaemia (ALL) cells and inhibits the proliferation of B-ALL cell lines
Br J Haematol, 136 (3), 400-13
DOI 10.1111/j.1365-2141.2006.06442.x, PubMed 17156404

Sivertsen EA, Hystad ME, Gutzkow KB, Døsen G, Smeland EB, Blomhoff HK, Myklebust JH (2006)
PI3K/Akt-dependent Epo-induced signalling and target genes in human early erythroid progenitor cells
Br J Haematol, 135 (1), 117-28
DOI 10.1111/j.1365-2141.2006.06252.x, PubMed 16965383

Kersten C, Dosen G, Myklebust JH, Sivertsen EA, Hystad ME, Smeland EB, Rian E (2006)
BMP-6 inhibits human bone marrow B lymphopoiesis--upregulation of Id1 and Id3
Exp Hematol, 34 (1), 72-81
DOI 10.1016/j.exphem.2005.09.010, PubMed 16413393

Kersten C, Sivertsen EA, Hystad ME, Forfang L, Smeland EB, Myklebust JH (2005)
BMP-6 inhibits growth of mature human B cells; induction of Smad phosphorylation and upregulation of Id1
BMC Immunol, 6, 9
DOI 10.1186/1471-2172-6-9, PubMed 15877825

Brattelid T, Kvingedal AM, Krobert KA, Andressen KW, Bach T, Hystad ME, Kaumann AJ, Levy FO (2004)
Cloning, pharmacological characterisation and tissue distribution of a novel 5-HT4 receptor splice variant, 5-HT4(i)
Naunyn Schmiedebergs Arch Pharmacol, 369 (6), 616-28
DOI 10.1007/s00210-004-0919-4, PubMed 15118808

Hystad ME, Oie E, Grøgaard HK, Kuusnemi K, Vuolteenaho O, Attramadal H, Hall C (2001)
Gene expression of natriuretic peptides and their receptors type-A and -C after myocardial infarction in rats
Scand J Clin Lab Invest, 61 (2), 139-50
DOI 10.1080/00365510151097665, PubMed 11347981

Hystad ME, Geiran OR, Attramadal H, Spurkland A, Vege A, Simonsen S, Hall C (2001)
Regional cardiac expression and concentration of natriuretic peptides in patients with severe chronic heart failure
Acta Physiol Scand, 171 (4), 395-403
DOI 10.1046/j.1365-201X.2001.00805.x, PubMed 11421854

Hystad ME, Klinge R, Spurkland A, Attramadal H, Hall C (2000)
Contrasting cardiac regional responses of A-type and B-type natriuretic peptide to experimental chronic heart failure
Scand J Clin Lab Invest, 60 (4), 299-309
DOI 10.1080/003655100750046468, PubMed 10943600

Kjekshus H, Smiseth OA, Klinge R, Oie E, Hystad ME, Attramadal H (2000)
Regulation of ET: pulmonary release of ET contributes to increased plasma ET levels and vasoconstriction in CHF
Am J Physiol Heart Circ Physiol, 278 (4), H1299-310
DOI 10.1152/ajpheart.2000.278.4.H1299, PubMed 10749728

Klinge R, Hystad M, Kjekshus J, Karlberg BE, Djøseland O, Aakvaag A, Hall C (1998)
An experimental study of cardiac natriuretic peptides as markers of development of congestive heart failure
Scand J Clin Lab Invest, 58 (8), 683-91
DOI 10.1080/00365519850186120, PubMed 10088206

Rofstad EK, Eide K, Skøyum R, Hystad ME, Lyng H (1996)
Apoptosis, energy metabolism, and fraction of radiobiologically hypoxic cells: a study of human melanoma multicellular spheroids
Int J Radiat Biol, 70 (3), 241-9
DOI 10.1080/095530096144978, PubMed 8800195

Hystad ME, Rofstad EK (1994)
Oxygen consumption rate and mitochondrial density in human melanoma monolayer cultures and multicellular spheroids
Int J Cancer, 57 (4), 532-7
DOI 10.1002/ijc.2910570416, PubMed 8181856

Rofstad EK, Wahl A, Hystad ME, Nesland JM, Stokke T (1991)
Establishment in monolayer culture and characterization of four human melanoma cell lines
Virchows Arch B Cell Pathol Incl Mol Pathol, 60 (3), 189-97
DOI 10.1007/BF02899546, PubMed 1679270

Rofstad EK, Zaffaroni N, Hystad ME (1990)
Heterogeneous radiation and heat sensitivity in vitro of human melanoma xenograft lines established from different lesions in the same patient. Comparisons with the radiation and heat sensitivity of cells isolated from the donor patient's surgical specimens
Int J Radiat Biol, 57 (6), 1113-22
DOI 10.1080/09553009014551231, PubMed 1971838

Review articles

Schüssler-Lenz M, Beuneu C, Menezes-Ferreira M, Jekerle V, Bartunek J, Chamuleau S, Celis P, Doevendans P, O'Donovan M, Hill J, Hystad M, Jovinge S, Kyselovič J, Lipnik-Stangelj M, Maciulaitis R, Prasad K, Samuel A, Tenhunen O, Tonn T, Rosano G, Zeiher A, Salmikangas P (2015)
Cell-based therapies for cardiac repair: a meeting report on scientific observations and European regulatory viewpoints
Eur J Heart Fail, 18 (2), 133-41
DOI 10.1002/ejhf.422, PubMed 26470631

Other articles

Committee for Advanced Therapies (CAT), CAT Scientific Secretariat, Schneider CK, Salmikangas P, Jilma B, Flamion B, Todorova LR, Paphitou A, Haunerova I, Maimets T, Trouvin JH, Flory E, Tsiftsoglou A, Sarkadi B, Gudmundsson K, O'Donovan M, Migliaccio G, Ancāns J, Maciulaitis R, Robert JL, Samuel A, Ovelgönne JH, Hystad M, Fal AM, Lima BS et al. (2010)
Challenges with advanced therapy medicinal products and how to meet them
Nat Rev Drug Discov, 9 (3), 195-201
DOI 10.1038/nrd3052, PubMed 20190786

Theses

Hystad ME (2001)
Origins of increased plasma concentrations of atrial- andbrain natriuretic peptid[e] in heart failure
Institute for Surgical Research, Rikshospitalet, The National Hospital, Department Group for Clinical Medecine, Faculty of Medicine, University of Oslo, [Oslo], 1 b. (flere pag.)
BIBSYS 011999616, ISBN 82-7722-150-9

Hystad ME (1992)
Metabolske og histologiske studier av humane melanomsfæroider
Det norske radiumhospital, Oslo, 97 bl.
BIBSYS 922457786